This site is intended for health professionals only

Editor’s pick

Bioterrorism expert to head the FDA
Bioterrorism expert to head the FDA
Bayer Schering presents positive results of phase II study with riociguat
Bayer Schering presents positive results of phase II study with riociguat
Vectura reports 24% rise in revenue
Vectura reports 24% rise in revenue
Risperdal Consta gets FDA approval
Risperdal Consta gets FDA approval
Swine-flu vaccine supplies assured in UK
Swine-flu vaccine supplies assured in UK
New era drug extends cancer patients’ lives
New era drug extends cancer patients’ lives
Lundbeck provides update on NDA for Serdolect
Lundbeck provides update on NDA for Serdolect
Shire to present ADHD treatment data
Shire to present ADHD treatment data
Boehringer Ingelheim presents new clinical data
Boehringer Ingelheim presents new clinical data
Chemo nausea ‘cut by use of ginger’
Chemo nausea ‘cut by use of ginger’
New colorectal and lung cancer study boost
New colorectal and lung cancer study boost
FDA approval for UCB RA drug
FDA approval for UCB RA drug
1 … 137 138 139 140 141 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x